))
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
…
continue reading
The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Sages of Psychopharmacology Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.
…
continue reading
1
Beyond Restraints: De-Escalation in Behavioral Emergencies
11:45
11:45
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:45
In this episode, we explore nonpharmacologic strategies for managing agitated patients, focusing on verbal de-escalation techniques. Did you know that using physical restraints adds an average of four hours to an emergency department stay? Dr. Scott Zeller shares evidence-based approaches to transform crisis intervention in emergency settings. Facu…
…
continue reading
1
Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial
13:34
13:34
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
13:34
In this episode, we explore the RADAR trial's findings on antipsychotic dose reduction in schizophrenia. Can patients with chronic schizophrenia safely reduce or discontinue their antipsychotic medications without increasing relapse risk? The trial's results challenge common assumptions about medication reduction and provide crucial guidance for cl…
…
continue reading
1
Unraveling Agitation: Mania vs. Substance Use
11:06
11:06
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:06
In this episode, we explore the challenges of diagnosing and managing agitation in emergency settings, focusing on mood disorders and substance use. Dr. Scott Zeller shares insights on differentiating acute mania from substance-induced psychosis. How can clinicians navigate the complex interplay between psychiatric symptoms and substance effects in…
…
continue reading
1
Pushing the Boundaries: Exploring High-Dose Antipsychotics
11:00
11:00
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:00
In this episode, we explore the use of high-dose olanzapine as a potential alternative to clozapine for treatment-resistant schizophrenia. We discuss a systematic review that examines the efficacy and safety of olanzapine doses above the FDA-approved maximum. Could high-dose olanzapine be a viable option when patients refuse clozapine? Faculty: Oli…
…
continue reading
1
The Psychodynamic Prescriber
15:19
15:19
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
15:19
In this episode, we explore how integrating psychodynamic principles into pharmacotherapy can enhance treatment outcomes. We discuss seven key features of psychodynamic psychotherapy and their application in routine psychiatric practice. How might understanding a patient's fantasies about their illness impact their response to medication? Faculty: …
…
continue reading
In this episode, we explore strategies for discontinuing benzodiazepines in hospitalized elderly patients. We discuss a recent Israeli study that tested two interventions during inpatient stays. Can a simple hospital-based intervention lead to successful long-term medication changes? Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D. Learn mo…
…
continue reading
1
The Power of Alliance in Psychopharmacology
14:14
14:14
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
14:14
In this episode, we explore the critical role of therapeutic alliance in psychopharmacology. We discuss how factors like empathy, communication, and shared decision-making can significantly impact treatment outcomes. Did you know that a doctor's warm voice can increase appointment adherence by 162%? Faculty: David Mintz, M.D. Host: Richard Seeber, …
…
continue reading
In this episode, we explore the cardiac and metabolic safety profile of antipsychotics in youth, based on a World Health Organization Safety Database analysis. We discuss age-dependent risks, specific medication concerns, and the importance of monitoring. How can clinicians balance the benefits of antipsychotics with potential cardiometabolic risks…
…
continue reading
1
The Double-Edged Sword of Biological Explanations in Mental Health
12:29
12:29
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
12:29
In this episode, we explore the unexpected consequences of promoting a purely biological view of mental illness. How does framing mental health conditions as solely biological affect stigma, patient outcomes, and physician empathy? We delve into the complex interplay between biological and psychosocial factors in mental health treatment. Faculty: D…
…
continue reading
1
New Insights into Psychiatric and Cardiovascular Comorbidity
11:15
11:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:15
In this episode, we explore the bidirectional relationship between psychiatric disorders and cardiovascular disease, discussing a groundbreaking study involving over 900,000 subjects. We ask: Can a mental health diagnosis increase your risk of heart disease? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our membership her E…
…
continue reading
